Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sorafenib in Patients With Extensive Keloids

NCT01425216 is registered in ClinicalTrials.gov with Tirgan, Michael H., M.D. as lead sponsor.

NCT NCT01425216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sorafenib in Patients With Extensive Keloids
Lead sponsor
Tirgan, Michael H., M.D.
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
March 31, 2013
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloids